Patricia Sanz
University of Chile
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Patricia Sanz.
American Journal of Medical Genetics Part A | 2003
Rosa A. Pardo Vargas; Gustavo Maegawa; Silvia Castillo Taucher; Júlio César L. Leite; Patricia Sanz; Juan Cifuentes; M. Parra; H. Muñoz; Carlos Magno Maranduba; Maria Rita Passos-Bueno
We report two patients with Beare‐Stevenson syndrome. This syndrome presents craniosynostosis with or without clover‐leaf skull, craniofacial anomalies, cutis gyrata, acanthosis nigricans, prominent umbilical stump, furrowed palms and soles, genital and anal anomalies. Both female newborn patients presented at birth with craniofacial anomalies, variable cutis gyrata in forehead and preauricular regions, prominent umbilical stump and anogenital anomalies. Furrowed palms and soles were also observed. The radiologic examination showed a cloverleaf‐form craniosynostosis. Chromosomes were normal. They were born with respiratory distress and were connected to mechanical ventilation for ventilatory support. Both of them died in 50 days after birth due to secondary complications. The molecular analysis of these patients identified the mutation Tyr375Cys in the FGFR2 gene.
Clinical Genetics | 2009
Gabriela M. Repetto; Ml Guzmán; Alonso Puga; Juan F. Calderon; Carmen Astete; Mariana Aracena; M Arriaza; Teresa Aravena; Patricia Sanz
Patients with chromosome 22q11 deletion syndrome exhibit significant phenotypic variability. Epidemiologic data suggest a higher incidence in Hispanics, but limited clinical information is available from Latin‐American patients. We describe the clinical features of Chilean patients with 22q11 deletion syndrome and compare their findings with those reported in large European, Japanese and US series. Data were obtained from 208 patients from five medical centers. Mean age at diagnosis was 5.2 years, with a median of 2.3 years. Congenital heart defects were present in 59.6%, lower than other large series that averaged 75.8%. Palate abnormalities were present in 79%, higher than previous reports averaging 56%. Patients with congenital heart disease were diagnosed earlier (median 0.3 years of age) than those without heart defects (median 5.6 years) and had greater mortality attributable to the syndrome (9.8% vs 2.4%, respectively). The differences in frequencies of major anomalies may be due to growing awareness of more subtle manifestations of the syndrome, differences in clinical ascertainment or the presence of modifier factors. These observations provide additional data useful for patient counseling and for the proposal of health care guidelines.
Revista Medica De Chile | 2004
Alexandre R Vieira; Silvia Castillo Taucher; Teresa Aravena; Carmen Astete; Patricia Sanz; María Eugenia Tastets; Luis Monasterio; Jeffrey C. Murray
BACKGROUND Mutations of the MSX1 gene may contribute to non-syndromic forms of cleft lip and/or cleft palate. AIM To search for mutations of MSX1 coding regions, including one highly conserved non-coding region in the single intron, among Chilean patients with cleft lip/palate. PATIENTS AND METHODS We studied 45 patients with cleft lip/palate and their parents. Oral mucosa samples were obtained with a swab. DNA was extracted and amplified by PCR. RESULTS Two missense mutations (G16D and G34A) were identified in this study that may be useful for future admixture studies. The G16D mutation appears to disrupt a possible splicing site and may contribute to clefting in this population. CONCLUSIONS Rare MSX1 mutations are found in some cases of cleft lip and/or cleft palate but others remain to be found most likely in other regulatory regions of the gene.
American Journal of Medical Genetics | 2000
Enrique Daniel Austin-Ward; Silvia Castillo; Yuri Dragnic; Patricia Sanz; Samuel Salazar; Joan H.M. Knoll
Marker chromosomes present a problem in genetic counseling because there are often no clear phenotype-karyotype correlations. We present the clinical findings in a patient who is mosaic for a supernumerary marker chromosome 20 determined by fluorescence in situ hybridization (FISH) and compare these findings to others reported in the literature.
Biological Research | 2009
Juan F. Calderon; Alonso Puga; M. Luisa Guzmán; Carmen Astete; Marta Arriaza; Mariana Aracena; Teresa Aravena; Patricia Sanz; Gabriela M. Repetto
Microdeletion 22q11 in humans causes velocardiofacial and DiGeorge syndromes. Most patients share a common 3Mb deletion, but the clinical manifestations are very heterogeneous. Congenital heart disease is present in 50-80% of patients and is a significant cause of morbidity and mortality. The phenotypic variability suggests the presence of modifiers. Polymorphisms in the VEGFA gene, coding for the vascular endothelial growth factor A, have been associated with non-syndromic congenital heart disease, as well as with the presence of cardiovascular anomalies in patients with microdeletion 22q11. We evaluated the association of VEGFA polymorphisms c.-2578C>A (rs699947), c.-1154G>A (rs1570360) and c.-634C>G (rs2010963) with congenital heart disease in Chilean patients with microdeletion 22q11. The study was performed using case-control and family-based association designs. We evaluated 122 patients with microdeletion 22q11 and known anatomy of the heart and great vessels, and their parents. Half the patients had congenital heart disease. We obtained no evidence of association by either method of analysis. Our results provide further evidence of the incomplete penetrance of the cardiovascular phenotype of microdeletion 22ql 1, but do not support association between VEGFA promoter polymorphisms and the presence of congenital heart disease in Chilean patients with this syndrome.
Revista chilena de obstetricia y ginecología | 2002
Alexis Inostroza C.; Héctor Navarro M.; Mario Paublo M.; H. Muñoz; Américo Hernández; Jorge Catalán; Patricia Sanz; Paula Puig
SUMMARY We present two clinical cases of prenatal diagnose of trisomy 9. This aneuploidy was suspected for first time in the ultrasound control that is performed during the second half of pregnancy, and was confirmed by cytogenetic cordocentesis or amniocentesis. We comment the behavior that’s supposed to be followed in these cases according to international standards. A literature survey is made emphasizing the small incidence of prenatal and postnatal diagnosis for this pathology.
American Journal of Medical Genetics Part A | 2011
Cristóbal Passalacqua; Camila Melo; Luz María Martín; Francisca Rojas; Patricia Sanz; Silvia Castillo Taucher; Ligia Aranibar
Marshall–Smith Syndrome (OMIM 602535) was described initially by Marshall in two infants with a syndrome characterized by accelerated skeletal maturation, failure to thrive, and dysmorphic facial features. We report a new patient with clinical features of Marshall–Smith syndrome with additional findings such as hyperpigmented lines on trunk and the four extremities.
Revista chilena de obstetricia y ginecología | 1991
Castillo S; Patricia Sanz; Astete C; Daher; Tobella L; Salazar S
Revista chilena de pediatría | 2016
Rosa A. Pardo Vargas; Mariana Aracena; Teresa Aravena; Carolina Cares; Fanny Cortés; Víctor Faundes; Cecilia Mellado; Cristóbal Passalacqua; Patricia Sanz; Silvia Castillo Taucher
Revista chilena de pediatría | 2016
Rosa A. Pardo Vargas; Mariana Aracena; Teresa Aravena; Carolina Cares; Fanny Cortés; Víctor Faundes; Cecilia Mellado; Cristóbal Passalacqua; Patricia Sanz; Silvia Castillo Taucher